RNS® System Pivotal Study

Completed · Phase 3 · Has a placebo group

Conditions studied: Epilepsy

In brief

The RNS® System Pivotal study is designed to assess safety and demonstrate that the RNS® System is effective as an adjunctive (add-on) therapy in reducing the frequency of seizures in individuals 18 years of age or older with partial onset seizures from no more than two foci (two areas of the brain) that are refractory (drug-resistant or hard-to-treat) to two or more antiepileptic medications. Patients continue to receive their epilepsy medications while participating in the study.

Key facts

Study ID
NCT00264810
Run by
NeuroPace
People needed
240
Starts
2005-12-01
Expected to finish
2011-05-01
Last updated by the study team
2013-08-28

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.